文献速递糖尿病

2型糖尿病血糖恶化的潜在过程:IMI DIRECT研究

Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study.
PubMed 文献 · Diabetes Care · 2020-12-15

该研究对732例新诊断2型糖尿病患者进行3年广泛表型分析,包括混合餐试验评估胰岛素敏感性、β细胞葡萄糖敏感性和胰岛素清除率,以及肝脏酶、血脂和MRI区域脂肪。结果显示,HbA1c恶化与胰岛素敏感性和β细胞功能恶化及胰岛素清除率增加独立相关,内脏或肝脏脂肪和血脂异常也有较弱作用;仅凭这些变量可清晰区分快速进展者(AUC=0.94)。

要点

  • 胰岛素敏感性、β细胞功能和胰岛素清除率恶化是血糖进展的关键驱动因素。
  • 稳定其中任一特征可将快速进展者比例从56%降至8-10%。
  • 多基因风险评分、胰腺脂肪、GLP-1、胰高血糖素、饮食和体力活动无独立作用。

核心结论

  • 胰岛素敏感性恶化和β细胞功能恶化、胰岛素清除率增加、内脏或肝脏脂肪高及血脂谱恶化是2型糖尿病初期血糖恶化的关键介导因素。
  • 稳定胰岛素敏感性、β细胞功能和胰岛素清除率中的单一特征可能有助于预防进展。

研究设计与样本

  • 研究纳入732例新诊断2型糖尿病患者,来自IMI DIRECT研究,进行3年广泛表型分析。
  • 采用混合餐试验评估胰岛素敏感性(OGIS)、β细胞葡萄糖敏感性(GS)和胰岛素清除率(CLIm),并检测肝脏酶、血脂谱和基线MRI区域脂肪。
  • 通过逐步多变量线性和逻辑回归评估纵向代谢模式与HbA1c恶化的关联,并校正BMI和糖尿病药物变化。

主要发现

  • 更快的HbA1c进展独立关联于更快的OGIS和GS恶化及CLIm增加;内脏或肝脏脂肪、HDL胆固醇和甘油三酯有进一步独立但较弱的作用(R²=0.38)。
  • 仅考虑这些变量即可清晰区分快速进展者亚组(AUC=0.94)。
  • 在OGIS、GS和CLIm中仅一个特征相对稳定的亚组中,快速进展者比例从56%降至8-10%(比值比0.07-0.09)。
  • 2型糖尿病多基因风险评分和基线胰腺脂肪、GLP-1、胰高血糖素、饮食和体力活动未显示独立作用。

临床怎么用

  • 在2型糖尿病早期,应关注胰岛素敏感性、β细胞功能和胰岛素清除率的动态变化,以识别快速进展风险患者。
  • 稳定胰岛素敏感性、β细胞功能或胰岛素清除率中的任一特征可能成为预防血糖恶化的干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated the processes underlying glycemic deterioration in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: A total of 732 recently diagnosed patients with T2D from the Innovative Medicines Initiative Diabetes Research on Patient Stratification (IMI DIRECT) study were extensively phenotyped over 3 years, including measures of insulin sensitivity (OGIS), β-cell glucose sensitivity (GS), and insulin clearance (CLIm) from mixed meal tests, liver enzymes, lipid profiles, and baseline regional fat from MRI. The associations between the longitudinal metabolic patterns and HbA1c deterioration, adjusted for changes in BMI and in diabetes medications, were assessed via stepwise multivariable linear and logistic regression. RESULTS: Faster HbA1c progression was independently associated with faster deterioration of OGIS and GS and increasing CLIm; visceral or liver fat, HDL-cholesterol, and triglycerides had further independent, though weaker, roles (R 2 = 0.38). A subgroup of patients with a markedly higher progression rate (fast progressors) was clearly distinguishable considering these variables only (discrimination capacity from area under the receiver operating characteristic = 0.94). The proportion of fast progressors was reduced from 56% to 8-10% in subgroups in which only one trait among OGIS, GS, and CLIm was relatively stable (odds ratios 0.07-0.09). T2D polygenic risk score and baseline pancreatic fat, glucagon-like peptide 1, glucagon, diet, and physical activity did not show an independent role. CONCLUSIONS: Deteriorating insulin sensitivity and β-cell function, increasing insulin clearance, high visceral or liver fat, and worsening of the lipid profile are the crucial factors mediating glycemic deterioration of patients with T2D in the initial phase of the disease. Stabilization of a single trait among insulin sensitivity, β-cell function, and insulin clearance may be relevant to prevent progression.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bizzotto R, Jennison C, Jones AG, et al. Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study. Diabetes Care. 2020. PMID: 33323478. doi:10.2337/dc20-1567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。